Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rafina Innovations's ROE % for the quarter that ended in Mar. 2019 was 0.00%. Rafina Innovations's PB Ratio for the quarter that ended in Mar. 2019 was N/A.
Rafina Innovations's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2019 was N/A.
Rafina Innovations ROE % Adjusted to Book Value Related Terms
Rafina Innovations ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Rafina Innovations's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rafina Innovations ROE % Adjusted to Book Value Chart
VICA vs RMSL, GTHP, DCTH: ROE % Adjusted to Book Value Comparison
For the Medical Devices subindustry, Rafina Innovations's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rafina Innovations ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Rafina Innovations's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Rafina Innovations's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 0.00% mean?
Rafina Innovations (VICA) has a ROE % Adjusted to Book Value of 0.00% as of Mar. 2019. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Rafina Innovations and its competitors.
Is Rafina Innovations' ROE % Adjusted to Book Value too high?
Rafina Innovations' current ROE % Adjusted to Book Value is 0.00%. Overall, Rafina Innovations has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Rafina Innovations' ROE % Adjusted to Book Value compare to RMSL and GTHP?
Rafina Innovations' ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Rafina Innovations and its competitors. Rafina Innovations's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rafina Innovations stock overvalued right now?
Rafina Innovations (VICA) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Rafina Innovations' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Rafina Innovations (VICA), the current ROE % Adjusted to Book Value is 0.00% as of Mar. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Rafina Innovations Inc through its subsidiaries is involved in the development of monitoring technologies, set up of rehabilitation centers, development of intellectual property related to everyday fields such as healthcare, sports, automotive and gaming as well as the creation of full-service Prosthetics and Orthotics and Diabetic foot clinics chain in Europe and the Middle East. The firm's main products include Flexisense technology and Rehabilitation clinics etc. It has Clinics and Technology operating segments and derives a majority of its revenues from Clinics segment.
12GF Score
Get the complete analysis for VICA
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VICA has been successfully added to your 
